Zheng Quan Zhi Xing·2025-08-13 14:09Core Viewpoint - The company, 技源集团, is utilizing raised funds to increase capital or provide loans to its wholly-owned subsidiary, 启东技源, for the implementation of investment projects, ensuring compliance with regulatory requirements and safeguarding the interests of the company and its shareholders [1][5][6] Fundraising Overview - The company has successfully issued 50.01 million shares at a price of 10.88 RMB per share, raising a total of 544.11 million RMB, with a net amount of 479.82 million RMB after deducting issuance costs of 64.29 million RMB [1][2] - The total investment for the projects funded by the raised capital is 602.73 million RMB, with the adjusted amount for the projects being 479.82 million RMB [2] Investment Project Details - The funds will be allocated to two main projects: the expansion of the nutrition and health food production line and the establishment of a technology innovation center, both managed by the subsidiary 启东技源 [2][3] - A total of 147.31 million RMB from the raised funds will be used for these projects, with the loan terms being flexible based on the actual needs of the projects [2][5] Subsidiary Information - 启东技源 is a wholly-owned subsidiary of the company, with a registered capital of 212.65 million RMB and a business scope that includes health food production and sales [3][4] - Recent financial data shows total assets of 344.98 million RMB, total liabilities of 56.37 million RMB, and net assets of 288.61 million RMB, with a revenue of 240.33 million RMB and a net profit of 32.78 million RMB [4] Impact on the Company - The use of raised funds for the subsidiary is aligned with the company's long-term strategic goals and ensures the smooth implementation of investment projects, maintaining control over financial risks [5][6] - The company has established a four-party supervision agreement to ensure the safe management of the raised funds, complying with relevant regulations [5][6] Approval Process - The board of directors and the supervisory board have approved the use of raised funds for the subsidiary, confirming that the process adheres to necessary approval protocols without requiring shareholder meeting approval [5][6] - The supervisory board has expressed that the funding allocation does not alter the intended use of the raised funds and does not harm the interests of the company or its shareholders [5][6]